ARK Invest’s Q4 2025 filing reveals a massive rotation. Wood trims Tesla and Palantir to load up on crypto infrastructure and biotech. See the full breakdown.
January's 130k jobs added smashed estimates, dropping unemployment to 4.3%. But massive revisions and a "delayed" Fed pivot complicate the soft landing.
Fisher Asset Management's Q4 2025 moves reveal a tactical shift into intermediate Treasuries and a massive rotation into AI hardware. Here is what it means.
Fed Governor Stephen Miran signals the central bank won't fight the weakening dollar, citing low inflation risks. With Kevin Warsh’s nomination looming, we analyze the shifting tides of US monetary policy and the path to a June rate cut.
Blackstone President Jon Gray argues that fears of an AI or credit bubble actually keep investors disciplined. We analyze his Nvidia vs. Cisco comparison and lessons from the Hilton deal.
TrumpRx goes live with $149 Wegovy and "most-favored-nation" pricing. We analyze the cash-only model, the pharma buy-in, and the "deductible trap" for patients.
Cathie Wood's ARK Invest snapped up $28.2 million in AMD shares after a 17% plunge. Is the "Oracle of Innovation" right about this AI bargain?
Deep dive into Davis Q4 2025 13F: Capital recycling strategy, the "Protein Pivot" (JBS, Tyson), and the rotation from AMAT to Energy.
Treasury Sec. Bessant claims the President has a "right" to influence the Fed. We analyze the market fallout, the Powell probe, and the battle for the dollar.
Software stocks hit a historic low relative to chips. We analyze the "5-sigma" divergence, Salesforce's plunge, and why DataTrek warns against buying the dip.